Skip to content

Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis

Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00608010
Enrollment
186
Registered
2008-02-06
Start date
2006-10-31
Completion date
Unknown
Last updated
2008-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertilization in Vitro, Preservation of Supernumerary Embryos

Keywords

Preservation of supernumerary embryos in an IVF program

Brief summary

Embryo preservation through freezing plays a significant role in human assisted reproduction. It provides an opportunity for patients to have more than one attempt following an ovarian stimulation cycle, thereby decreasing the exposure of patients to exogenous gonadotrophins and improving cumulative pregnancy rates. The purpose of this study is to compare effectiveness of two different freezing methods.

Interventions

PROCEDUREVitrification

Embryos were vitrified according to a previously described technique

PROCEDURESlow freezing

Embryos were frozen with slow freezing technique

Sponsors

V.K.V. American Hospital, Istanbul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ICSI with own gametes * Couples who did not wish to cryopreserve their excess embryos for possible transfer in a future cyle * Donating excess embryos for research purposes

Exclusion criteria

* Embryos derived from surgically retrieved spermatozoa * Blastocysts * Embryos of low quality (Grade 3 or 4 according to Hardarson)

Design outcomes

Primary

MeasureTime frame
Blastocyst development rate3 days after thawing

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026